| Title |
Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study
|
|---|---|
| Published in |
Drug, Healthcare and Patient Safety, June 2013
|
| DOI | 10.2147/dhps.s45347 |
| Pubmed ID | |
| Authors |
Izumi Sato, Manabu Akazawa |
| Abstract |
The concomitant use of multiple medications by elderly patients with hypertension is a relatively common and growing phenomenon in Japan. This has been attributed to several factors, including treatment guidelines recommending prescription of multiple medications and a continuing increase in the elderly population with multiple comorbidities. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 17% |
| Japan | 1 | 17% |
| Unknown | 4 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 2% |
| Unknown | 65 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 10 | 15% |
| Student > Master | 10 | 15% |
| Student > Bachelor | 10 | 15% |
| Researcher | 8 | 12% |
| Other | 5 | 8% |
| Other | 12 | 18% |
| Unknown | 11 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 25 | 38% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 21% |
| Computer Science | 2 | 3% |
| Chemistry | 2 | 3% |
| Mathematics | 1 | 2% |
| Other | 5 | 8% |
| Unknown | 17 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2016.
All research outputs
#6,266,276
of 25,461,852 outputs
Outputs from Drug, Healthcare and Patient Safety
#60
of 160 outputs
Outputs of similar age
#49,277
of 206,691 outputs
Outputs of similar age from Drug, Healthcare and Patient Safety
#3
of 4 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 160 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 206,691 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.